Recent advances in the treatment of organophosphorous poisonings

Iranian Journal of Medical Sciences

Volumn 37, Issue 2, 2012, Pages 74-91

  Balali Mood, Mahdi ^a   Saber, Hamidreza ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atropine; Neurotoxicity; Organophosphorous; Oxime; Treatment

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 1 [2,4 BIS(HYDROXYIMINOMETHYL)PYRIDINIO] 1' (4 CARBAMOYLPYRIDINIO)DIMETHYL ETHER DIIODIDE; ACTIVATED CARBON; ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIOXIDANT; APROFENE; ATROPINE; BENACTYZINE; BENZODIAZEPINE; BICARBONATE; BIS(PYRIDINIUM OXIME) DERIVATIVE; CARAMIPHEN; DIAZEPAM; GACYCLIDINE; GLYCOPYRRONIUM BROMIDE; KETAMINE; MAGNESIUM SULFATE; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT; OBIDOXIME; ORGANOPHOSPHATE PESTICIDE; ORGANOPHOSPHORUS COMPOUND; OXIME; PAM 2; PHYSOSTIGMINE; PRALIDOXIME; PYRIDOSTIGMINE; TEZAMPANEL; TRIMEDOXIME; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACCOMMODATION PARALYSIS; ACUTE TOXICITY; ADJUVANT THERAPY; ANXIETY DISORDER; BLURRED VISION; CHRONIC TOXICITY; CONVULSION; DELAYED NEUROTOXICITY; DETOXIFICATION; DIPLOPIA; DISEASE CONTROL; DISEASE SEVERITY; DISORDERS OF ACID BASE BALANCE; DIZZINESS; DOSE RESPONSE; DRUG BRAIN LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENCY; DRUG POTENTIATION; DRUG SAFETY; ENZYME ACTIVITY; ENZYME INHIBITION; FASCICULATION; HEADACHE; HEMATOLOGIC DISEASE; HEMOFILTRATION; HUMAN; INTOXICATION; LONG TERM EXPOSURE; LOW DRUG DOSE; METABOLIC ACIDOSIS; NAUSEA; NEUROPATHY; NONHUMAN; ORGANOPHOSPHOROUS POISONING; OUTCOME ASSESSMENT; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; RECOMMENDED DRUG DOSE; RESTLESSNESS; REVIEW; SEIZURE; THERAPY DELAY; TOXICOKINETICS; TREATMENT DURATION; TREATMENT PLANNING;

EID: 84862741858     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Review

References (136)

1. Afshari R, Majdzadeh R, Balali-Mood M. Pattern of acute poisonings in Mashhad, Iran 1993-2000. J Toxicol Clin Toxicol. 2004;42:965-975. pubMed PMID: 15641642.
2. Balali-Mood M, Shariat M. Treatment of organophosphate poisoning. Experience of nerve agents and acute pesticide poisoning on the effects of oximes. J Physiol Paris. 1998;92:375-378. pubMed PMID: 9789840.
3. Eddleston M, Gunnell D, Karunaratne A, de Silva D, Sheriff MH, Buckley NA. Epidemiology of intentional self-poisoning in rural Sri Lanka. Br J Psychiatry. 2005;187:583-584. doi: 10.1192/ bjp.187.6.583. pubMed PMID: 16319413; pubMed Central PMCID: PMC1475924.
4. Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. QJM. 2000;93:715-731. doi: 10.1093/ qjmed/93.11.715. pubMed PMID: 11077028.
5. Pohanka M, Musilek K, Kuca K. Progress of biosensors based on cholinesterase inhibition. Curr Med Chem. 2009;16:1790-1798. doi: 10.2174/092986709788186129. pubMed PMID: 19442145.
6. Newmark J. Nerve agents. Neurologist. 2007;13:20-32. doi: 10.1097/01.nrl. 0000252923.04894.53. pubMed PMID: 17215724.
7. Newmark J. Nerve agents: pathophysiology and treatment of poisoning. Semin Neurol. 2004;24:185-196. doi: 10.1055/s-2004-830906. pubMed PMID: 15257516.
8. Gunderson CH, Lehmann CR, Sidell FR, Jabbari B. Nerve agents: a review. Neurology. 1992;42:946-950. pubMed PMID: 1315942.
9. Vale A. What lessons can we learn from the Japanese sarin attacks? Przegl Lek. 2005;62:528-532. pubMed PMID: 16225116.
10. Okumura T, Takasu N, Ishimatsu S, Miyanoki S, Mitsuhashi A, Kumada K, et al. Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med. 1996;28:129-135. doi: 10.1016/S0196-0644(96)70052-5. pubMed PMID: 8759575.
11. Yanagisawa N, Morita H, Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J Neurol Sci. 2006;249:76-85. doi: 10.1016/j.jns.2006.06.007. pubMed PMID: 16962140.
12. Jeyaratnam J, Maroni M. Organophosphorous compounds. Toxicology. 1994;91:15-27. doi: 10.1016/0300-483X(94)90236-4. pubMed PMID: 8052981.
13. Newmark J. Nerve agents. Neurol Clin. 2005;23:623-641. doi: 10.1016/j.ncl. 2004.12.013. pubMed PMID: 15757800.
14. Leikin JB, Thomas RG, Walter FG, Klein R, Meislin HW. A review of nerve agent exposure for the critical care physician. Crit Care Med. 2002;30:2346-2354. doi: 10.1097/00003246-200210000-00026. pubMed PMID: 12394966.
15. Chemical casualties. Nerve agents. J R Army Med Corps. 2002;148:344-357. pubMed PMID: 12703422.
16. Worek F, Aurbek N, Wetherell J, Pearce P, Mann T, Thiermann H. Inhibition, reactivation and aging kinetics of highly toxic organophos-phorus compounds: pig versus minipig ace-tylcholinesterase. Toxicology. 2008;244:35-41. doi: 10.1016/j.tox.2007.10.021. pubMed PMID: 18054823.
17. Jokanović M. Biotransformation of organo-phosphorus compounds. Toxicology. 2001;166:139-160. doi: 10.1016/S0300-483X(01)00463-2. pubMed PMID: 11543910.
18. Jokanović M. Medical treatment of acute poisoning with organophosphorus and carba-mate pesticides. Toxicol Lett. 2009;190:107-115. doi: 10.1016/j.toxlet.2009.07.025. pubMed PMID: 19651196
19. Hulet SW, McDonough JH, Shih TM. The dose-response effects of repeated subacute sarin exposure on guinea pigs. Pharmacol Biochem Behav. 2002;72:835-845. doi: 10.1016/S0091-3057(02)00761-X. pubMed PMID: 12062573.
20. Sogorb MA, Vilanova E. Enzymes involved in the detoxification of organophosphorus, carbamate and pyrethroid insecticides through hydrolysis. Toxicol Lett. 2002;128:215-228. doi: 10.1016/S0378-4274(01)00543-4. pubMed PMID: 11869832.
21. Mumford H, Troyer JK. Post-exposure therapy with recombinant human BuChE following percutaneous VX challenge in guinea-pigs. Toxicol Lett. 2011;206:29-34. doi: 10.1016/j.toxlet.2011.05.1016. pubMed PMID: 21620937; pubMed Central PMCID: PMC3159811.
22. Jokanović M. Current understanding of the mechanisms involved in metabolic detoxification of warfare nerve agents. Toxicol Lett. 2009;188:1-10. doi: 10.1016/j. toxlet.2009.03.017. pubMed PMID: 19433263.
23. Worek F, Eyer P, Aurbek N, Szinicz L, Thiermann H. Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis. Toxicol Appl Pharmacol. 2007;219:226-234. doi: 10.1016/j. taap.2006.10.001. pubMed PMID: 17112559.
24. Worek F, Koller M, Thiermann H, Szinicz L. Diagnostic aspects of organophosphate poisoning. Toxicology. 2005;214:182-189. doi: 10.1016/j.tox.2005.06.012. pubMed PMID: 16051411.
25. Nakajima T, Sasaki K, Ozawa H, Sekjima Y, Morita H, Fukushima Y, et al. Urinary metabolites of sarin in a patient of the Matsumoto sarin incident. Arch Toxicol. 1998;72:601-603. doi: 10.1007/s002040050549. pubMed PMID: 9806433.
26. Jokanović M, Kosanović M, Maksimović M. Interaction of organophosphorus compounds with carboxylesterases in the rat. Arch Toxicol. 1996;70:444-450. doi: 10.1007/ s002040050297. pubMed PMID: 8740539.
27. Black RM. An overview of biological markers of exposure to chemical warfare agents. J Anal Toxicol. 2008;32:2-9. pubMed PMID: 18269786.
28. Lotti M, Moretto A. Cholinergic symptoms and Gulf War syndrome. Nat Med. 1995;1:1225-1226. doi: 10.1038/nm1295-1225b. pubMed PMID: 7489390.
29. Black RM. History and perspectives of bio-analytical methods for chemical warfare agent detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:1207-1215. doi: 10.1016/j.jchromb.2009.11.025. pubMed PMID: 20018570.
30. Lee JH, Park JY, Min K, Cha HJ, Choi SS, Yoo YJ. A novel organophosphorus hydro-lase-based biosensor using mesoporous carbons and carbon black for the detection of organophosphate nerve agents. Biosens Bioelectron. 2010;25:1566-1570. doi: 10.1016/j. bios.2009.10.013. pubMed PMID: 20093002.
31. Mawhinney DB, Hamelin EI, Fraser R, Silva SS, Pavlopoulos AJ, Kobelski RJ. The determination of organophosphonate nerve agent metabolites in human urine by hydrophilic interaction liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007;852:235-243. doi: 10.1016/j.jchromb.2007.01.023. pubMed PMID: 17289448.
32. Swaim LL, Johnson RC, Zhou Y, Sandlin C, Barr JR. Quantification of organophosphorus nerve agent metabolites using a reduced-volume, high-throughput sample processing format and liquid chromatography-tandem mass spectrometry. J Anal Toxicol. 2008;32:774-777. pubMed PMID: 19021934.
33. van der Meer JA, Trap HC, Noort D, van der Schans MJ. Comprehensive gas chromatography with Time of Flight MS and large volume introduction for the detection of fluoride-induced regenerated nerve agent in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2010;878:1320-1325. pubMed PMID: 20308021.
34. Polhuijs M, Langenberg JP, Benschop HP. New method for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists. Toxicol Appl Pharmacol. 1997;146:156-161. doi: 10.1006/ taap.1997.8243. pubMed PMID: 9299607.
35. Fidder A, Hulst AG, Noort D, de Ruiter R, van der Schans MJ, Benschop HP, et al. Retrospective detection of exposure to organo-phosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem Res Toxicol. 2002;15:582-590. doi: 10.1021/tx0101806. pubMed PMID: 11952345.
36. Read RW, Riches JR, Stevens JA, Stubbs SJ, Black RM. Biomarkers of organophosphorus nerve agent exposure: comparison of phosphylated butyrylcholinesterase and phosphylated albumin after oxime therapy. Arch Toxicol. 2010;84:25-36. doi: 10.1007/s00204-009-0473-4. pubMed PMID: 19862504.
37. Schier JG, Ravikumar PR, Nelson LS, Heller MB, Howland MA, Hoffman RS. Preparing for chemical terrorism: stability of injectable atropine sulfate. Acad Emerg Med. 2004;11:329-334. doi: 10.1197/j.aem.2003.06.014. pubMed PMID: 15064203.
38. Anzueto A, Berdine GG, Moore GT, Gleiser C, Johnson D, White CD, et al. Pathophysiology of soman intoxication in primates. Toxicol Appl Pharmacol. 1986;86:56-68. doi: 10.1016/0041-008X(86)90399-6. pubMed PMID: 3764936.
39. Huang YJ, Lundy PM, Lazaris A, Huang Y, Baldassarre H, Wang B, et al. Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albumin. BMC Biotechnol. 2008;8:50. doi: 10.1186/1472-6750-8-50. pubMed PMID: 18485214.
40. Williams NH, Harrison JM, Read RW, Black RM. Phosphylated tyrosine in albumin as a biomarker of exposure to organophosphorus nerve agents. Arch Toxicol. 2007;81:627-639. doi: 10.1007/s00204-007-0191-8. pubMed PMID: 17345062.
41. Satoh T, Hosokawa M. Organophosphates and their impact on the global environment. Neurotoxicology. 2000;21:223-227. pubMed PMID: 10794404.
42. Balali-Mood M, Balali-Mood K. Neurotoxic disorders of organophosphorus compounds and their managements. Arch Iran Med. 2008;11:65-89. pubMed PMID: 18154426.
43. Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia. 1999;54:1073-1088. doi: 10.1046/j.1365-2044.1999.01061.x. pubMed PMID: 10540097.
44. Tokuda Y, Kikuchi M, Takahashi O, Stein GH. Prehospital management of sarin nerve gas terrorism in urban settings: 10 years of progress after the Tokyo subway sarin attack. Resuscitation. 2006;68:193-202. doi: 10.1016/j.resuscitation.2005.05.023. pubMed PMID: 16325985.
45. GROB D. The manifestations and treatment of poisoning due to nerve gas and other organic phosphate anticholinesterase compounds. AMA Arch Intern Med. 1956;98:221-239. doi: 10.1001/archinte.1956.00250260095010. pubMed PMID: 13354016.
46. Jamal GA. Neurological syndromes of organo-phosphorus compounds. Adverse Drug React Toxicol Rev. 1997;16:133-170. pubMed PMID: 9512762.
47. Rastogi SK, Tripathi S, Ravishanker D. A study of neurologic symptoms on exposure to organophosphate pesticides in the children of agricultural workers. Indian J Occup Environ Med. 2010;14:54-57. doi: 10.4103/0019-5278.72242. pubMed PMID: 21120082.
48. Weinbroum AA. Pathophysiological and clinical aspects of combat anticholinesterase poisoning. Br Med Bull. 2005;72:119-133. doi: 10.1093/bmb/ldh038. pubMed PMID: 15845747.
49. Sidell FR. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin Toxicol. 1974;7:1-17. doi: 10.3109/15563657408987971. pubMed PMID: 4838227.
50. Paudyal BP. Organophosphorus poisoning. JNMA J Nepal Med Assoc. 2008;47:251-258. pubMed PMID: 19079407.
51. Rickett DL, Glenn JF, Beers ET. Central respiratory effects versus neuromuscular actions of nerve agents. Neurotoxicology. 1986;7:225-236. pubMed PMID: 3714123.
52. Worek F, Kleine A, Falke K, Szinicz L. Arrhythmias in organophosphate poisoning: effect of atropine and bispyridinium oximes. Arch Int Pharmacodyn Ther. 1995;329:418-435. pubMed PMID: 8546540.
53. Chacko J, Elangovan A. Late onset, prolonged asystole following organophosphate poisoning: a case report. J Med Toxicol. 2010;6:311-314. doi: 10.1007/s13181-010-0095-5. pubMed PMID: 20532843.
54. Perkins MW, Pierre Z, Rezk P, Sabnekar P, Kabra K, Chanda S, et al. Acute respiratory toxicity following inhalation exposure to soman in guinea pigs. Toxicol Appl Pharmacol. 2010;245:171-178. doi: 10.1016/j. taap.2010.02.016. pubMed PMID: 20206646.
55. Vijayakumar S, Fareedullah M, Ashok Kumar E, Mohan Rao K. A prospective study on electrocardiographic fndings of patients with organophosphorus poisoning. Cardiovasc Toxicol. 2011;11:113-117. doi: 10.1007/s12012-011-9104-4. doi: 10.1007/s12012-011-9104-4. pubMed PMID: 21336997.
56. Shadnia S, Okazi A, Akhlaghi N, Sasanian G, Abdollahi M. Prognostic value of long QT interval in acute and severe organophos-phate poisoning. J Med Toxicol. 2009;5:196-199. doi: 10.1007/BF03178266. pubMed PMID: 19876851.
57. Yurumez Y, Yavuz Y, Saglam H, Durukan P, Ozkan S, Akdur O, et al. Electrocardiographic findings of acute organophosphate poisoning. J Emerg Med. 2009;36:39-42. doi: 10.1016/j.jemermed.2007.08.063. pubMed PMID: 18296005.
58. Singer AW, Jaax NK, Graham JS, McLeod CG Jr. Cardiomyopathy in Soman and Sarin intoxicated rats. Toxicol Lett. 1987;36:243-249. doi: 10.1016/0378-4274(87)90192-5. pubMed PMID: 3590220.
59. Guadarrama-Naveda M, de Cabrera LC, Matos-Bastidas S. Intermediate syndrome secondary to ingestion of chlorpiriphos. Vet Hum Toxicol. 2001;43:34. pubMed PMID: 11205075.
60. Yang CC, Deng JF. Intermediate syndrome following organophosphate insecticide poisoning. J Chin Med Assoc. 2007;70:467-472. doi: 10.1016/S1726-4901(08)70043-1. pubMed PMID: 18063499.
61. Jokanović M, Kosanović M. Neurotoxic effects in patients poisoned with organophosphorus pesticides. Environ Toxicol Pharmacol. 2010;29:195-201. doi: 10.1016/j. etap.2010.01.006. pubMed PMID: 21787602.
62. De Bleecker JL. Intermediate Syndrome in Organophosphate Poisoning. In: Ramesh CG, editor. Toxicology of Organophosphate & Carbamate Compounds. Burlington: Academic Press; 2006. p. 371-380.
63. De Bleecker J, Vogelaers D, Ceuterick C, Van Den Neucker K, Willems J, De Reuck J. Intermediate syndrome due to prolonged parathion poisoning. Acta Neurol Scand. 1992;86:421-424. pubMed PMID: 1455989.
64. McLeod CG Jr, Singer AW, Harrington DG. Acute neuropathology in soman poisoned rats. Neurotoxicology. 1984;5:53-57. pubMed PMID: 6542190.
65. Emerick GL, Peccinini RG, de Oliveira GH. Organophosphorus-induced delayed neuropathy: a simple and effcient therapeutic strategy. Toxicol Lett. 2010;192:238-244. doi: 10.1016/j.toxlet.2009.10.032. pubMed PMID: 19914363.
66. Johnson MK. The mechanism of delayed neuropathy caused by some organophosphorus esters: using the understanding to improve safety. J Environ Sci Health B. 1980;15:823-841. doi: 10.1080/03601238009372219. pubMed PMID: 7002990.
67. Tan DH, Peng SQ, Wu YL, Wang YM, Lu CF, Yan CH. Chronic organophosphate (OP)-induced neuropsychiatric disorder is a withdrawal syndrome. Med Hypotheses. 2009;72:405-406. doi: 10.1016/j.mehy.2008.11.026. pubMed PMID: 19131175.
68. Jalali N, Balali-Mood M, Jalali I, Shakeri MT. Electrophysiological changes in patients with acute organophosphorous pesticide poisoning. Basic Clin Pharmacol Toxicol. 2011;108:251-255. doi: 10.1111/j.1742-7843.2010.00652.x. pubMed PMID: 21156031.
69. Fullerton CS, Ursano RJ. Behavioral and psychological responses to chemical and biological warfare. Mil Med. 1990;155:54-59. pubMed PMID: 2106650.
70. Lallement G. [Overview on neurogenesis induced by organophosphate poisoning: results and perspectives]. Ann Pharm Fr. 2007;65:415-421. pubMed PMID: 18079674.
71. Riddle JR, Brown M, Smith T, Ritchie EC, Brix KA, Romano J. Chemical warfare and the Gulf War: a review of the impact on Gulf veterans' health. Mil Med. 2003;168:606-613. pubMed PMID: 12943034.
72. Masson P. Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol Lett. 2011;206:5-13. doi: 10.1016/j.toxlet.2011.04.006. pubMed PMID: 21524695.
73. Tang FR, Loke WK, Ling EA. Comparison of status epilepticus models induced by pilocarpine and nerve agents - a systematic review of the underlying aetiology and adopted therapeutic approaches. Curr Med Chem. 2011;18:886-899. pubMed PMID: 21182477.
74. Angoa-Pérez M, Kreipke CW, Thomas DM, Van Shura KE, Lyman M, McDonough JH, et al. Soman increases neuronal COX-2 levels: possible link between seizures and protracted neuronal damage. Neurotoxi-cology. 2010;31:738-746. doi: 10.1016/j. neuro.2010.06.007. pubMed PMID: 20600289; pubMed Central PMCID: PMC2974036.
75. Shih TM, Duniho SM, McDonough JH. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol. 2003;188:69-80. doi: 10.1016/ S0041-008X(03)00019-X. pubMed PMID: 12691725.
76. Sharabi Y, Danon YL, Berkenstadt H, Almog S, Mimouni-Bloch A, Zisman A, et al. Survey of symptoms following intake of pyridostigmine during the Persian Gulf war. Isr J Med Sci. 1991;27:656-658. pubMed PMID: 1757241.
77. Koskela H, Hakala U, Vanninen P. Structural characterization of chemical warfare agent degradation products in decontamination solutions with proton band-selective (1)H-(31)P NMR spectroscopy. Anal Chem. 2010;82:5331-5340. pubMed PMID: 20507069.
78. Amitai G, Murata H, Andersen JD, Koepsel RR, Russell AJ. Decontamination of chemical and biological warfare agents with a single multi-functional material. Biomaterials. 2010;31:4417-4425. doi: 10.1016/j.biomateri-als.2010.02.004. pubMed PMID: 20199807.
79. Collombet JM. Nerve agent intoxication: recent neuropathophysiological findings and subsequent impact on medical management prospects. Toxicol Appl Pharmacol. 2011;255:229-241. doi: 10.1016/j.taap.2011.07.003. pubMed PMID: 21791221.
80. Kanugula AK, Repalle ER, Pandey JP, Sripad G, Mitra CK, Dubey DK, et al. Immobilization of organophosphate hydrolase on biocompatible gelatin pads and its use in removal of organophosphate compounds and nerve agents. Indian J Biochem Biophys. 2011;48:29-34. pubMed PMID: 21469599.
81. Lenz DE, Yeung D, Smith JR, Sweeney RE, Lumley LA, Cerasoli DM. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review. Toxicology. 2007;233:31-39. doi: 10.1016/j. tox.2006.11.066. pubMed PMID: 17188793.
82. Raveh L, Grunwald J, Marcus D, Papier Y, Cohen E, Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization. Biochem Pharmacol. 1993;45:2465-2474. pubMed PMID: 8328984.
83. Caranto GR, Waibel KH, Asher JM, Larrison RW, Brecht KM, Schutz MB, et al. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes. Biochem Pharmacol. 1994;47:347-357. doi: 10.1016/0006-2952(94)90026-4. pubMed PMID: 8304979.
84. Saxena A, Maxwell DM, Quinn DM, Radić Z, Taylor P, Doctor BP. Mutant acetylcholines-terases as potential detoxification agents for organophosphate poisoning. Biochem Pharmacol. 1997;54:269-274. doi: 10.1016/S0006-2952(97)00180-9. pubMed PMID: 9271331.
85. Mizrahi DM, Saphier S, Columbus I. Efficient heterogeneous and environmentally friendly degradation of nerve agents on a tungsten-based POM. J Hazard Mater. 2010;179:495-499. doi: 10.1016/j.jhazmat.2010.03.030. pubMed PMID: 20363072.
86. Mikler J, Tenn C, Worek F, Reiter G, Thiermann H, Garrett M, et al. Immobilization of Russian VX skin depots by localized cooling: implications for decontamination and medical countermeasures. Toxicol Lett. 2011;206:47-53. doi: 10.1016/j.toxlet.2011.05.1047. pubMed PMID: 21704135.
87. Sawyer TW, Mikler J, Worek F, Reiter G, Thiermann H, Tenn C, et al. The therapeutic use of localized cooling in the treatment of VX poisoning. Toxicol Lett. 2011;204:52-56. doi: 10.1016/j.toxlet.2011.04.008. pubMed PMID: 21530621.
88. Blain PG. Organophosphorus poisoning (acute). Clin Evid. 2011;2011. pii: 2102. pubMed PMID: 21575287.
89. [Cases of poisoning from organophosphoric insecticides and verification method for their exposure]. Chudoku Kenkyu. 2008;21:133-140. pubMed PMID: 18516937.
90. McDonough JH Jr, McLeod CG Jr, Nipwoda MT. Direct microinjection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology. Brain Res. 1987;435:123-137. doi: 10.1016/0006-8993(87)91593-9. pubMed PMID: 3427447.
91. Antonijevic B, Stojiljkovic MP. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning. Clin Med Res. 2007;5:71-82. doi: 10.3121/cmr.2007.701. pubMed PMID: 17456837; pubMed Central PMCID: PMC1855336.
92. Zilker T. Medical management of incidents with chemical warfare agents. Toxicology. 2005;214:221-231. doi: 10.1016/j. tox.2005.06.028. pubMed PMID: 16098652.
93. Shih TM, Rowland TC, McDonough JH. Anti-convulsants for nerve agent-induced seizures: The infuence of the therapeutic dose of atropine. J Pharmacol Exp Ther. 2007;320:154-161. doi: 10.1124/jpet.106.111252. pubMed PMID: 17015638.
94. Ohbu S, Yamashina A, Takasu N, Yamaguchi T, Murai T, Nakano K, et al. Sarin poisoning on Tokyo subway. South Med J. 1997;90:587-593. doi: 10.1097/00007611-199706000-00002. pubMed PMID: 9191733.
95. Shockley LW. The use of inhaled nebulized atropine for the treatment of malathion poisoning. J Toxicol Clin Toxicol. 1989;27:183-192. doi: 10.3109/15563658909038582. pubMed PMID: 2810443.
96. Eyer P. The role of oximes in the management of organophosphorus pesticide poisoning. Toxicol Rev. 2003;22:165-190. doi: 10.2165/00139709-200322030-00004. pubMed PMID: 15181665.
97. Dunn MA, Sidell FR. Progress in medical defiense against nerve agents. JAMA. 1989;262:649-652. doi: 10.1001/ jama.262.5.649. pubMed PMID: 2664236.
98. Ashani Y, Bhattacharjee AK, Leader H, Saxena A, Doctor BP. Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators. Biochem Pharmacol. 2003;66:191-202. doi: 10.1016/ S0006-2952(03)00204-1. pubMed PMID: 12826262.
99. Jokanović M, Prostran M. Pyridinium oximes as cholinesterase reactivators. Structure-activity relationship and efficacy in the treatment of poisoning with organophosphorus compounds. Curr Med Chem. 2009;16:2177-2188. doi: 10.2174/092986709788612729. pubMed PMID: 19519385.
100. Grange-Messent V, Bouchaud C, Jamme M, Lallement G, Foquin A, Carpentier P. Seizure-related opening of the blood-brain barrier produced by the anticholinesterase compound, soman: new ultrastructural observations. Cell Mol Biol (Noisy-le-grand). 1999;45:1-14. pubMed PMID: 10099835.
101. Joosen MJ, van der Schans MJ, van Dijk CG, Kuijpers WC, Wortelboer HM, van Helden HP. Increasing oxime efficacy by blood-brain barrier modulation. Toxicol Lett. 2011;206:67-71. doi: 10.1016/j.toxlet.2011.05.231. pubMed PMID: 21600273.
102. Kalisiak J, Ralph EC, Zhang J, Cashman JR. Amidine-oximes: reactivators for organophos-phate exposure. J Med Chem. 2011;54:3319-3330. doi: 10.1021/jm200054r. pubMed PMID: 21438612.
103. Valiyaveettil M, Alamneh Y, Rezk P, Biggemann L, Perkins MW, Sciuto AM, et al. Protective efficacy of catalytic bioscavenger, paraoxonase 1 against sarin and soman exposure in guinea pigs. Biochem Pharmacol. 2011;81:800-809. doi: 10.1016/j.bcp.2010.12.024. pubMed PMID: 21219877.
104. Kassa J, Karasova J, Musilek K, Kuca K, Bajgar J. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice. Clin Toxicol. 2009;47:72-76. doi: 10.1080/15563650802043652. pubMed PMID: 18686075.
105. Buckley NA, Eddleston M, Li Y, Bevan M, Robertson J. Oximes for acute organophosphate pesticide poisoning. Cochrane Database Syst Rev. 2011;2:CD005085. pubMed PMID: 21328273.
106. Kassa J, Kuca K, Cabal J. A comparison of the potency of trimedoxime and other currently available oximes to reactivate tabun-inhibited acetylcholinesterase and eliminate acute toxic effects of tabun. Biomed Pap Med Fac Univ Palacky Olomouc Czech Re pub. 2005;149:419-423. pubMed PMID: 16601802.
107. Shahroukhi A, Ghasemi A, Poorabdolhossein F, Asgari A, Khoshbaten A. The effect of paraoxon on GABA uptake in rat cerebellar synaptosomes. Med Sci Monit. 2007;13:194-199. pubMed PMID: 17767114.
108. Lewin L, Mattsson MO, Sellström A. Inhibition of transporter mediated gamma-aminobutyric acid (GABA) release by SKF 89976-A, a GABA uptake inhibitor, studied in a primary neuro-nal culture from chicken. Neurochem Res. 1992;17:577-584. pubMed PMID: 1603264.
109. Cannard K. The acute treatment of nerve agent exposure. J Neurol Sci. 2006;249:86-94. doi: 10.1016/j.jns.2006.06.008. pubMed PMID: 16945386.
110. Marrs TC. The role of diazepam in the treatment of nerve agent poisoning in a civilian population. Toxicol Rev. 2004;23:145-157. doi: 10.2165/00139709-200423030-00002. pubMed PMID: 15862082.
111. Johnson MK, Vale JA, Marrs TC, Meredith TJ. Pralidoxime for organophosphorus poisoning. Lancet. 1992;340:64. doi: 10.1016/0140-6736(92)92487-Z. pubMed PMID: 1351653.
112. Kassa J. [Effect of diazepam on the effectiveness of antidote therapy in eliminating the acute lethal effects of soman in mice]. Cas Lek Cesk. 2001;140:497-499. pubMed PMID: 11678028.
113. Capacio BR, Byers CE, Merk KA, Smith JR, McDonough JH. Pharmacokinetic studies of intramuscular midazolam in guinea pigs challenged with soman. Drug Chem Toxicol. 2004;27:95-110. doi: 10.1081/DCT-120030727. pubMed PMID: 15198070.
114. Gilat E, Kadar T, Levy A, Rabinovitz I, Cohen G, Kapon Y, et al. Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: an electrographic, behavioral, and histological study in freely moving rats. Toxicol Appl Pharmacol. 2005;209:74-85. doi: 10.1016/j. taap.2005.03.007. pubMed PMID: 16271623.
115. Lallement G, Clarençon D, Galonnier M, Bau-bichon D, Burckhart MF, Peoc'h M. Acute soman poisoning in primates neither pre-treated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support. Arch Toxicol. 1999;73:115-122. doi: 10.1007/s002040050595. pubMed PMID: 10350192.
116. Balali-Mood M, Ayati MH, Ali-Akbarian H. Effect of high doses of sodium bicarbonate in acute organophosphorous pesticide poisoning. Clin Toxicol (Phila). 2005;43:571-574. doi: 10.1081/CLT-200068845. pubMed PMID: 16255339.
117. Pajoumand A, Shadnia S, Rezaie A, Abdi M, Abdollahi M. Benefts of magnesium sulfate in the management of acute human poisoning by organophosphorus insecticides. Hum Exp Toxicol. 2004;23:565-569. doi: 10.1191/0960327104ht489oa. pubMed PMID: 15688984.
118. Singh G, Avasthi G, Khurana D, Whig J, Mahajan R. Neurophysiological monitoring of pharmacological manipulation in acute organophosphate (OP) poisoning. The effects of pralidoxime, magnesium sulphate and pancuronium. Electroencephalogr Clin Neuro-physiol. 1998;107:140-148. doi: 10.1016/S0013-4694(98)00053-4. pubMed PMID: 9751285.
119. Liu WF. A symptomatological assessment of organophosphate-induced lethality in mice: comparison of atropine and clonidine protection. Toxicol Lett. 1991;56:19-32. pubMed PMID: 2017778.
120. Ranjbar A, Solhi H, Mashayekhi FJ, Susanabdi A, Rezaie A, Abdollahi M. Oxidative stress in acute human poisoning with organophospho-rus insecticides; a case control study. Environ Toxicol Pharmacol. 2005;20:88-91. doi: 10.1016/j.etap.2004.10.007. pubMed PMID: 21783573.
121. John S, Kale M, Rathore N, Bhatnagar D. Protective effect of vitamin E in dimethoate and malathion induced oxidative stress in rat erythrocytes. J Nutr Biochem. 2001;12:500-504. doi: 10.1016/S0955-2863(01)00160-7. pubMed PMID: 11834209.
122. Peng A, Meng FQ, Sun LF, Ji ZS, Li YH. Therapeutic efficacy of charcoal hemoperfusion in patients with acute severe dichlorvos poisoning. Acta Pharmacol Sin. 2004;25:15-21. pubMed PMID: 14704117.
123. Güven M, Sungur M, Eser B, Sari I, Altuntaş F. The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning. J Toxicol Clin Toxicol. 2004;42:617-623. doi: 10.1081/ CLT-200026967. pubMed PMID: 15462154.
124. Pichamuthu K, Jerobin J, Nair A, John G, Kamalesh J, Thomas K, et al. Bioscavenger therapy for organophosphate poisoning - an open-labeled pilot randomized trial comparing fresh frozen plasma or albumin with saline in acute organophosphate poisoning in humans. Clin Toxicol. 2010;48:813-819. doi: 10.3109/15563650.2010.518970. pubMed PMID: 20923392.
125. Masson P. Evolution of and perspectives on therapeutic approaches to nerve agent poisoning. Toxicol Lett. 2011;206:5-13. doi: 10.1016/j.toxlet.2011.04.006. pubMed PMID: 21524695.
126. Collombet JM, Four E, Burckhart MF, Masque-liez C, Bernabé D, Baubichon D, et al. Effect of cytokine treatment on the neurogenesis process in the brain of soman-poisoned mice. Toxicology. 2005;210:9-23. doi: 10.1016/j. tox.2005.01.013. pubMed PMID: 15804454.
127. Collombet JM, Béracochéa D, Liscia P, Pié-rard C, Lallement G, Filliat P. Long-term effects of cytokine treatment on cognitive behavioral recovery and neuronal regeneration in soman-poisoned mice. Behav Brain Res. 2011;221:261-270. doi: 10.1016/j. bbr.2011.03.006. pubMed PMID: 21396966.
128. Sogorb MA, Vilanova E, Carrera V. Future applications of phosphotriesterases in the prophylaxis and treatment of organophospo-rus insecticide and nerve agent poisonings. Toxicol Lett. 2004;151:219-233. doi: 10.1016/j. toxlet.2004.01.022. pubMed PMID: 15177657.
129. Everley PA, Dillman JF 3rd. Genomics and proteomics in chemical warfare agent research: recent studies and future applications. Toxicol Lett. 2010;198:297-303. doi: 10.1016/j.toxlet.2010.08.003. pubMed PMID: 20708669.
130. Gaydess A, Duysen E, Li Y, Gilman V, Kabanov A, Lockridge O, et al. Visualization of exogenous delivery of nanoformulated butyrylcholinesterase to the central nervous system. Chem Biol Interact. 2010;187:295-298. doi: 10.1016/j.cbi.2010.01.005. pubMed PMID: 20060815; pubMed Central PMCID: PMC2998607.
131. McDonough JH, McMonagle JD, Shih TM. Time-dependent reduction in the anticon-vulsant effectiveness of diazepam against soman-induced seizures in guinea pigs. Drug Chem Toxicol. 2010;33:279-283. doi: 10.3109/01480540903483417. pubMed PMID: 20429808.
132. Husain K, Ansari RA, Ferder L. Pharmacological agents in the prophylaxis/treatment of organophosphorous pesticide intoxication. Indian J Exp Biol. 2010;48:642-650. pubMed PMID: 20929049.
133. Coleman BR, Ratcliffe RH, Oguntayo SA, Shi X, Doctor B P, Gordon RK, et al. [+]-Huper-zine A treatment protects against N-methyl-d-aspartate-induced seizure/status epilepticus in rats. Chem Biol Interact. 2008;175:387-395. doi: 10.1016/j.cbi.2008.05.023. pubMed PMID: 18588864.
134. Weissman BA, Raveh L. Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutama-tergic properties. Toxicol Appl Pharmacol. 2008;232:351-358. pubMed PMID: 18680758.
135. Dorandeu F, Baille V, Mikler J, Testylier G, Lallement G, Sawyer T, et al. Protective effects of S+ ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs. Toxicology. 2007;234:185-193. doi: 10.1016/j. tox.2007.02.012. pubMed PMID: 17408839.
136. Figueiredo TH, Qashu F, Apland JP, Aroni-adou-Anderjaska V, Souza AP, Braga MF. The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology. J Pharmacol Exp Ther. 2011;336:303-312. pubMed PMID: 20962029; pubMed Central PMCID: PMC3033714.